Drug intelligence / Profile preview

Aqua Maris

Development stage: Unknown
Lead developer: JGL Group
Administration: Intranasal

Overview

Aqua Maris (Aquamaris) is a line of natural nasal sprays and drops developed by the Croatian pharmaceutical company JGL (Jadran-galenski laboratorij) and distributed in Indonesia by SOHO Global Health. The products are formulated from purified, mineral-rich Adriatic seawater, which is available in both isotonic and hypertonic concentrations. Aqua Maris works through physical and osmotic mechanisms to cleanse, moisturize, and reduce swelling of the nasal mucosa. It is widely used to relieve nasal congestion associated with colds, flu, sinusitis, and allergies, as well as for daily nasal hygiene and post-operative care.

Brand names: Aqua MarisAqua Maris BabyAqua Maris CleanAqua Maris DailyAqua Maris HypertonicAqua Maris PlusAqua Maris StrongAquamaris
Other names: sea waterseawaterseawater nasal spraysodium chloride nasal spray

Beyond the preview

Go deeper on Aqua Maris.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aqua Maris.

Explore the full profile